pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
413
stories
Apr 28, 26
Coultreon banks $125M to support testing of former Galapagos immune drug
biopharma dive
Apr 28, 26
Predicting consequences of new hepatitis B vaccine recs
stat
Apr 28, 26
Galapagos spinout Coultreon raises $125M for new take on SIK inhibition
endpoints
Apr 28, 26
Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
biopharma dive
Apr 27, 26
New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies project
stat
Apr 27, 26
Lilly to buy startup Ajax in bid for a better JAK drug
biopharma dive
Apr 27, 26
What’s the true risk for eating disorders with GLP-1s?
stat
Apr 27, 26
STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study
stat
Apr 27, 26
What happened to Covid?
stat
Apr 25, 26
Nancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77
stat
Apr 25, 26
Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs
stat
Apr 25, 26
Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and more
endpoints
Apr 24, 26
STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B
stat
Apr 24, 26
Sanofi MS drug rejected in US gets an endorsement in Europe
biopharma dive
Apr 24, 26
Opinion: The local news crisis is also a public health crisis
stat
Apr 23, 26
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
biopharma dive
Apr 23, 26
STAT+: Sanofi research priorities in flux as new CEO logs in
stat
Apr 23, 26
Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs
biopharma dive
Apr 23, 26
Sanofi posts upbeat sales as R&D pressure builds
biopharma dive
Apr 23, 26
Sanofi defends Garijo appointment, says it is 'fully committed' to immunology
endpoints
Apr 22, 26
Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
biopharma dive
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffers
fiercebiotech
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77M
fiercebiotech
← prev
page 14 of 14
next →
